During the coronavirus pandemic, scientists have appealed to people suffering from a mild form of Covid-19, in new European research.
This is particularly the case in Mons, where Professor Jérôme Lechien now administers a treatment to patients with anosmia… And which is already promising in terms of results.
Anosmia: what is it?
Anosmia results in a loss of smell, temporarily or permanently, of one or both nostrils. If this disorder is difficult to assess, it is considered that less than 5% of the population suffers. Anosmia can be associated with a disturbance of the sense of taste, or even a total loss, then called ageusia.
The impact of the smell disorder on those affected is quite substantial: “Some odors have almost disappeared while others are greatly altered”explains Yves Baste, an anosmic patient for five years: “We lose all flavor. Eating isn’t really pleasant anymore.”
In addition to this non-negligible impact on the daily life of patients, this situation can even prove to be dangerous in certain cases, such as the non-detection of gas or burning odors, for example.
